EUVIMEDEUVIMED entdecken
Systematische Übersicht

699 Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: A Systematic Review

A Awais, K R Nazareth, A Mustafa

British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)

DOI: 10.1093/bjs/znag063.306 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von A Awais und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Severe symptomatic tricuspid regurgitation (TR) is associated with right-sided heart failure, functional limitations, and reduced quality of life. Transcatheter tricuspid valve intervention (TTVI), particularly transcatheter edge-to-edge repair (T-TEER), offers a less invasive alternative for patients unsuitable for surgery. This review evaluates randomised evidence on clinical outcomes of T-TEER compared with optimised medical therapy (OMT) in patients with ≥ severe TR.

Method

A systematic review of randomised controlled trials was conducted using PubMed, Embase, and Cochrane Library up to March 2025. Six RCTs (n = 2,150) met inclusion criteria. Data were extracted on demographics, baseline comorbidities, TR reduction, quality of life, and adverse events. Risk of bias was assessed using the Cochrane risk-of-bias (RoB 2) tool.

Results

Participants were elderly (mean age 78.6 years), predominantly female (67%), with frequent heart failure, atrial fibrillation, and diabetes (16%). Across trials, T-TEER reduced TR severity to ≤ moderate in > 80% of patients, improving symptoms and functional status. The TRI.Fr trial reported clinical improvement in 74.1% versus 40.6% of controls, with a +15.9 KCCQ gain. TRILUMINATE showed durable benefits, including a 28% reduction in heart-failure hospitalisations and KCCQ improvements of +13 to +15. TRISCEND II confirmed parallel improvements with transcatheter replacement, showing a +17.8-point KCCQ advantage and 64.6% of treated patients alive and well at one year. Major adverse events were <5%, and overall bias risk was low.

Conclusions

T-TEER yields substantial, durable improvements in symptoms, function, and quality of life in severe TR, with fewer heart-failure hospitalisations. Mortality benefit remains unproven, warranting longer-term follow-up.

Zitieren

APA

Awais, A., Nazareth, K. R., & Mustafa, A. (2026). 699 Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: A Systematic Review. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.306

Vancouver

Awais A, Nazareth KR, Mustafa A. 699 Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: A Systematic Review. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.306

BibTeX
@article{Awais2026,
  author = {Awais, A and Nazareth, K R and Mustafa, A},
  title = {699 Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: A Systematic Review},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_6},
  doi = {10.1093/bjs/znag063.306}
}
Kostenlos starten →